Biogen Inc. Price Today
Biogen Inc.
BIIB
Healthcare
$29.79B
💰
Market Cap
25.7
💸
Price to Earnings
$8.0
🎉
EPS
+78
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
20 |
Strong Buy |
10 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
BIIB Price Forecast Target
204.9 👉 500.0 +144%
BIIB EPS Forecast
8.0 👉 17.6 +121%
Financials
Profit Margin
12 %
Revenue Growth
-6.2 %
Dividend
$ 0
Held Percent
0.7% - Insiders
93.0% - Institutions
6.3% - Public
Major Fund Holders
-
💰 Primecap Management Company $3.3B
-
💰 Vanguard Group Inc $3.0B
-
💰 Blackrock Inc. $2.9B
-
💰 State Street Corporation $1.4B
-
💰 T. Rowe Price Investment Management, Inc. $1.1B
Stock Ideas
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…📮FAQ
Some Frequently Asked Questions.
The Biogen Inc. industry is Drug Manufacturers - General
The Biogen Inc. sector is Healthcare
The Biogen Inc. forecasted predicted Price to Earnings PE ratio is 11.6
The Biogen Inc. Price to Earnings PE ratio is 25.7
The Market Capitalization of Biogen Inc. is $29.79B
There are total of 144811334 float shares with 93.0% held by Institutions and 0.7% held by insiders
The MBiogen Inc. forecasted Earnings per Share EPS is $17.6
The Biogen Inc. Earnings per Share EPS is 8.0
The Biogen Inc. company has $0 gross profits with 12 profit margins
The Biogen Inc. Earnings Growth is -0.549% with -0.546% quarterly earnings growth
The Biogen Inc. Revenue is $9835599872 with -0.062 revenue growth
The price target for Biogen Inc. stock is $500.0 for the high target and $215.0 for the low target
The consensus analyst recommendations for Biogen Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Biogen Inc. is Buy, with the following breakdown:
- Buy: 20
- Strong Buy: 10
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of Biogen Inc. is -0.0
The dividend of Biogen Inc. is $0
The dividend yield of Biogen Inc. is 0%
The biggest institutional and mutual fund holders of Biogen Inc. stock are
- Primecap Management Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Biogen Inc. ESG Score is 78, with the following breakdown:
- E: 0.42
- S: 14.46
- G: 7.37